成人人群中高频率的化脓性链球菌Cas9反应性T细胞
该研究探讨了健康成人对化脓性链球菌Cas9(SpCas9)的预存T细胞免疫。研究发现存在广泛分布的SpCas9反应性效应T细胞,并对其CD4/CD8区室的多效应功能、细胞毒性和谱系进行了表征。深度分析显示高频率的SpCas9反应性调节性T细胞可在体外抑制效应T细胞增殖和功能,为克服预存免疫问题提供了可能方案。
要点
- 健康成人中存在针对SpCas9的预存效应T细胞反应。
- SpCas9反应性T细胞涵盖CD4和CD8区室,具多效应潜能和细胞毒性。
- 高频率SpCas9反应性调节性T细胞可在体外抑制效应T细胞功能。
核心结论
- 健康成人中存在针对SpCas9的普遍预存效应T细胞反应。
- SpCas9反应性调节性T细胞可在体外减弱效应T细胞的增殖和功能。
研究设计与样本
- 研究分析了健康成人中对SpCas9的预存T细胞反应。
- 对SpCas9反应性T细胞进行了CD4/CD8区室的多效应功能、细胞毒性和谱系表征。
主要发现
- 健康人体内存在针对SpCas9的预存普遍效应T细胞反应。
- SpCas9反应性T细胞在CD4/CD8区室中具有多效应潜能和细胞毒性。
- SpCas9反应性T细胞中调节性T细胞频率高,可在体外抑制效应T细胞增殖和功能。
临床怎么用
- 提示CRISPR-Cas9基因治疗需考虑预存T细胞免疫对疗效和安全性的影响。
- 调节性T细胞可能为克服预存免疫提供潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The discovery of the highly efficient site-specific nuclease system CRISPR-Cas9 from Streptococcus pyogenes has galvanized the field of gene therapy1,2. The immunogenicity of Cas9 nuclease has been demonstrated in mice3,4. Preexisting immunity against therapeutic gene vectors or their cargo can decrease the efficacy of a potentially curative treatment and may pose significant safety issues3-6. S. pyogenes is a common cause for infectious diseases in humans, but it remains unclear whether it induces a T cell memory against the Cas9 nuclease7,8. Here, we show the presence of a preexisting ubiquitous effector T cell response directed toward the most widely used Cas9 homolog from S. pyogenes (SpCas9) within healthy humans. We characterize SpCas9-reactive T cells within the CD4/CD8 compartments for multi-effector potency, cytotoxicity, and lineage determination. In-depth analysis of SpCas9-reactive T cells reveals a high frequency of SpCas9-reactive regulatory T cells that can mitigate SpCas9-reactive effector T cell proliferation and function in vitro. Our results shed light on T cell-mediated immunity toward CRISPR-associated nucleases and offer a possible solution to overcome the problem of preexisting immunity.
引用
- Wagner DL, Amini L, Wendering DJ, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2018. PMID: 30374197. doi:10.1038/s41591-018-0204-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。